Guía de Práctica Clínica sobre Trastorno Bipolar - GuíaSalud

52. Ruggero CJ, Chelminski I, Young D y Zimmerman M. Psychosocial impairment
associated with bipolar II disorder. J Affect Disord, 2007; 104 (1-3): 53-60.
53. Goldstein TR, Birmaher B, Axelson D, Goldstein BI, Gill MK, Esposito-Smythers C,
Ryan ND, Strober MA, Hunt J y Keller M. Psychosocial functioning among bipolar
youth. J Affect Disord, 2009; 114 (1-3): 174-183.
54. Goetz I, Tohen M, Reed C, Lorenzo M y Vieta E. Functional impairment in patients with
mania: baseline results of the EMBLEM study. Bipolar Disord, 2007; 9 (1-2): 45-52.
55. Huxley N y Baldessarini RJ. Disability and its treatment in bipolar disorder patients.
Bipolar Disord, 2007; 9 (1-2): 183-196.
56. Rosa AR, Franco C, Martinez-Aran A, Sanchez-Moreno J, Reinares M, Salamero M,
Arango C, Ayuso-Mateos JL, Kapczinski F y Vieta E. Functional impairment in patients
with remitted bipolar disorder. Psychother Psychosom, 2008; 77 (6): 390-392.
57. DelBello MP, Hanseman D, Adler CM, Fleck DE y Strakowski SM. Twelve-month
outcome of adolescents with bipolar disorder following first hospitalization for a manic
or mixed episode. Am J Psychiatry, 2007; 164 (4): 582-590.
58. Sierra P, Livianos L y Rojo L. Quality of life for patients with bipolar disorder:
relationship with clinical and demographic variables. Bipolar Disord, 2005; 7 (2): 159-
165.
59. Osby U, Brandt L, Correia N, Ekbom A y Sparen P. Excess mortality in bipolar and
unipolar disorder in Sweden. Arch Gen Psychiatry, 2001; 58 (9): 844-850.
60. Harris EC y Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis.
Br J Psychiatry, 1997; 170: 205-228.
61. Tondo L, Isacsson G y Baldessarini R. Suicidal behaviour in bipolar disorder: risk and
prevention. CNS Drugs, 2003; 17 (7): 491-511.
62. Angst J. [Epidemiology of the bipolar spectrum]. Encephale, 1995; 21 Spec No 6: 37-42.
63. Baldessarini RJ, Tondo L y Hennen J. Effects of lithium treatment and its discontinuation
on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry, 1999; 60
Suppl 2: 77-84; discussion 111-116.
64. Dilsaver SC, Chen YW, Swann AC, Shoaib AM y Krajewski KJ. Suicidality in patients
with pure and depressive mania. Am J Psychiatry, 1994; 151 (9): 1312-1315.
65. Isometsa ET, Aro HM, Henriksson MM, Heikkinen ME y Lonnqvist JK. Suicide in major
depression in different treatment settings. J Clin Psychiatry, 1994; 55 (12): 523-527.
66. Strakowski SM, McElroy SL, Keck PE, Jr. y West SA. Suicidality among patients with
mixed and manic bipolar disorder. Am J Psychiatry, 1996; 153 (5): 674-676.
67. Bidzinska EJ. Stress factors in affective diseases. Br J Psychiatry, 1984; 144: 161-166.
68. Kessler RC, Zhao S, Blazer DG y Swartz M. Prevalence, correlates, and course of minor
depression and major depression in the National Comorbidity Survey. J Affect Disord,
1997; 45 (1-2): 19-30.
69. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL y Goodwin FK.
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the
Epidemiologic Catchment Area (ECA) Study. JAMA, 1990; 264 (19): 2511-2518.
70. Fogarty F, Russell JM, Newman SC y Bland RC. Epidemiology of psychiatric disorders
in Edmonton. Mania. Acta Psychiatr Scand Suppl, 1994; 376: 16-23.
71. Mueser KT, Yarnold PR y Bellack AS. Diagnostic and demographic correlates of
substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand,
1992; 85 (1): 48-55.
72. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B y Schwartz JE. Prevalence
and severity of substance use disorders and onset of psychosis in first-admission
psychotic patients. Psychol Med, 1998; 28 (6): 1411-1419.
GUÍA DE PRÁCTICA CLÍNICA SOBRE TRASTORNO BIPOLAR 403